IL143761A0 - Biodegradable polymer encapsulated serotonin receptor antagonist and method for preparing the same - Google Patents

Biodegradable polymer encapsulated serotonin receptor antagonist and method for preparing the same

Info

Publication number
IL143761A0
IL143761A0 IL14376199A IL14376199A IL143761A0 IL 143761 A0 IL143761 A0 IL 143761A0 IL 14376199 A IL14376199 A IL 14376199A IL 14376199 A IL14376199 A IL 14376199A IL 143761 A0 IL143761 A0 IL 143761A0
Authority
IL
Israel
Prior art keywords
preparing
same
receptor antagonist
biodegradable polymer
serotonin receptor
Prior art date
Application number
IL14376199A
Other languages
English (en)
Original Assignee
Aventis Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Inc filed Critical Aventis Pharma Inc
Publication of IL143761A0 publication Critical patent/IL143761A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Addiction (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Biological Depolymerization Polymers (AREA)
IL14376199A 1998-12-16 1999-11-22 Biodegradable polymer encapsulated serotonin receptor antagonist and method for preparing the same IL143761A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US21298698A 1998-12-16 1998-12-16
PCT/US1999/027705 WO2000035423A1 (en) 1998-12-16 1999-11-22 Biodegradable polymer encapsulated serotonin receptor antagonist and method for preparing the same

Publications (1)

Publication Number Publication Date
IL143761A0 true IL143761A0 (en) 2002-04-21

Family

ID=22793267

Family Applications (2)

Application Number Title Priority Date Filing Date
IL14376199A IL143761A0 (en) 1998-12-16 1999-11-22 Biodegradable polymer encapsulated serotonin receptor antagonist and method for preparing the same
IL143761A IL143761A (en) 1998-12-16 2001-06-14 Particles of a biodegradable polymer containing a serotonin receptor antagonist and method of preparation

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL143761A IL143761A (en) 1998-12-16 2001-06-14 Particles of a biodegradable polymer containing a serotonin receptor antagonist and method of preparation

Country Status (35)

Country Link
EP (1) EP1140026B1 (sr)
JP (1) JP4759141B2 (sr)
KR (1) KR100707710B1 (sr)
CN (1) CN1195497C (sr)
AP (1) AP1769A (sr)
AR (1) AR021652A1 (sr)
AT (1) ATE303795T1 (sr)
AU (1) AU770673B2 (sr)
BG (1) BG65500B1 (sr)
BR (1) BR9916276A (sr)
CA (1) CA2355077C (sr)
CR (1) CR6424A (sr)
CZ (1) CZ301947B6 (sr)
DE (1) DE69927177T2 (sr)
DK (1) DK1140026T3 (sr)
EA (1) EA004502B1 (sr)
EE (1) EE200100314A (sr)
ES (1) ES2245128T3 (sr)
HK (1) HK1041645B (sr)
HR (1) HRP20010446A2 (sr)
HU (1) HU226586B1 (sr)
ID (1) ID28909A (sr)
IL (2) IL143761A0 (sr)
ME (2) MEP19408A (sr)
NO (1) NO20012981L (sr)
NZ (1) NZ511962A (sr)
OA (1) OA11728A (sr)
PL (1) PL196822B1 (sr)
RS (1) RS50123B (sr)
SK (1) SK285812B6 (sr)
TR (1) TR200101759T2 (sr)
TW (1) TWI221418B (sr)
UA (1) UA73101C2 (sr)
WO (1) WO2000035423A1 (sr)
ZA (1) ZA200104899B (sr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10061932A1 (de) * 2000-12-13 2002-10-24 Pharmatech Gmbh Wirkstoffhaltige Mikropartikel und Verfahren zur Herstellung der Mikropartikel durch Abrasion
AU2002256694A1 (en) * 2001-03-20 2002-10-03 Euroscreen S.A. Screening, diagnostic and/or dosage method and device of an agonist and/or antagonist for a calcium-coupled receptor
SK14182003A3 (sk) * 2001-05-23 2004-05-04 Hexal Ag Homogenizát pre implantáty a mikročastice
US20050215561A1 (en) * 2004-03-19 2005-09-29 Krishnendu Ghosh Pharmaceutical dosage forms and compositions
KR20070059161A (ko) * 2004-09-21 2007-06-11 산동 루예 파마슈티칼 컴파니 리미티드 도파민 수용체 효능제를 함유하는 장시간 작용 서방성 제제및 그 제조방법
US8377453B2 (en) 2008-03-11 2013-02-19 Depomed, Inc. Gastric retentive extended-release dosage forms comprising combinations of a non-opioid analgesic and an opioid analgesic
US8372432B2 (en) 2008-03-11 2013-02-12 Depomed, Inc. Gastric retentive extended-release dosage forms comprising combinations of a non-opioid analgesic and an opioid analgesic
BRPI0913724B8 (pt) * 2008-09-18 2021-05-25 Purdue Pharma Lp formas farmacêuticas de liberação prolongada compreendendo naltrexona e poli (e-caprolactona) e seu preparo
US20100291214A1 (en) * 2008-12-23 2010-11-18 Armark Authentication Technologies, Llc Three-dimensional microfiber extrudate structure and process for forming three-dimensional microfiber extrudate structure
WO2010151746A2 (en) * 2009-06-26 2010-12-29 Armark Authentication Technologies, Llc Three-dimensional microfiber extrudate structure and process for forming three-dimensional microfiber extrudate structure
US8597681B2 (en) 2009-12-22 2013-12-03 Mallinckrodt Llc Methods of producing stabilized solid dosage pharmaceutical compositions containing morphinans
US9198861B2 (en) 2009-12-22 2015-12-01 Mallinckrodt Llc Methods of producing stabilized solid dosage pharmaceutical compositions containing morphinans
US8858963B1 (en) 2011-05-17 2014-10-14 Mallinckrodt Llc Tamper resistant composition comprising hydrocodone and acetaminophen for rapid onset and extended duration of analgesia
US8741885B1 (en) 2011-05-17 2014-06-03 Mallinckrodt Llc Gastric retentive extended release pharmaceutical compositions
US9050335B1 (en) 2011-05-17 2015-06-09 Mallinckrodt Llc Pharmaceutical compositions for extended release of oxycodone and acetaminophen resulting in a quick onset and prolonged period of analgesia
US20160193151A1 (en) * 2015-01-06 2016-07-07 Maria Del Pilar Noriega Escobar Dosage form incorporating an amorphous drug solid solution
US11672755B2 (en) * 2019-12-31 2023-06-13 Wanka Tanka Ltd. Extended release plastic formulation

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4389330A (en) * 1980-10-06 1983-06-21 Stolle Research And Development Corporation Microencapsulation process
DE3612212A1 (de) * 1986-04-11 1987-10-15 Basf Ag Verfahren zur herstellung von festen pharmazeutischen formen
US5439688A (en) * 1989-07-28 1995-08-08 Debio Recherche Pharmaceutique S.A. Process for preparing a pharmaceutical composition
CH679207A5 (sr) * 1989-07-28 1992-01-15 Debiopharm Sa
DK0528978T3 (da) * 1990-05-16 2003-02-17 Southern Res Inst Mikrokapsler til reguleret afgivelse og deres anvendelse i stimulering af nervefibervækst
KR100211713B1 (ko) * 1990-06-01 1999-08-02 슈테펜 엘. 네스비트 (+)-알파-(2,3-디메톡시페닐)-1-[2-(4-플루오로페닐)에틸]-4-피페리딘메탄올
GB9016885D0 (en) * 1990-08-01 1990-09-12 Scras Sustained release pharmaceutical compositions
KR0182801B1 (ko) * 1991-04-16 1999-05-01 아만 히데아키 고체 분산체의 제조방법
US5505963A (en) * 1993-04-07 1996-04-09 Schwartz Pharma Ag Slow release pharmaceutical preparation
US5456917A (en) * 1993-04-12 1995-10-10 Cambridge Scientific, Inc. Method for making a bioerodible material for the sustained release of a medicament and the material made from the method
AU4467396A (en) * 1994-12-12 1996-07-10 Omeros Medical Systems, Inc. Irrigation solution and method for inhibition of pain, inflammation and spasm

Also Published As

Publication number Publication date
KR20010082359A (ko) 2001-08-29
CR6424A (es) 2004-02-26
CZ20012157A3 (cs) 2001-09-12
BG65500B1 (bg) 2008-10-31
EP1140026B1 (en) 2005-09-07
PL348233A1 (en) 2002-05-20
YU41401A (sh) 2003-12-31
HUP0105048A3 (en) 2002-09-30
MEP19408A (en) 2010-06-10
AU770673B2 (en) 2004-02-26
AR021652A1 (es) 2002-07-31
EA200100551A1 (ru) 2001-10-22
HK1041645A1 (en) 2002-07-19
CN1330536A (zh) 2002-01-09
CA2355077C (en) 2009-05-26
ID28909A (id) 2001-07-12
PL196822B1 (pl) 2008-02-29
SK285812B6 (sk) 2007-08-02
RS50123B (sr) 2009-03-25
HK1041645B (zh) 2005-07-29
EE200100314A (et) 2002-08-15
DK1140026T3 (da) 2006-01-02
NO20012981L (no) 2001-07-27
ATE303795T1 (de) 2005-09-15
WO2000035423A1 (en) 2000-06-22
DE69927177D1 (de) 2005-10-13
JP4759141B2 (ja) 2011-08-31
ES2245128T3 (es) 2005-12-16
TWI221418B (en) 2004-10-01
NZ511962A (en) 2003-06-30
EA004502B1 (ru) 2004-04-29
NO20012981D0 (no) 2001-06-15
JP2002532408A (ja) 2002-10-02
TR200101759T2 (tr) 2001-12-21
OA11728A (en) 2005-02-01
SK8282001A3 (en) 2001-11-06
HUP0105048A2 (hu) 2002-05-29
HRP20010446A2 (en) 2002-06-30
CZ301947B6 (cs) 2010-08-11
KR100707710B1 (ko) 2007-04-18
IL143761A (en) 2006-08-01
BR9916276A (pt) 2001-09-04
UA73101C2 (en) 2005-06-15
AP1769A (en) 2007-08-22
AU1742500A (en) 2000-07-03
DE69927177T2 (de) 2006-06-08
WO2000035423A9 (en) 2002-08-22
BG105591A (en) 2002-01-31
CN1195497C (zh) 2005-04-06
EP1140026A1 (en) 2001-10-10
AP2001002198A0 (en) 2001-09-30
CA2355077A1 (en) 2000-06-22
HU226586B1 (en) 2009-04-28
ME00066B (me) 2010-06-10
ZA200104899B (en) 2002-09-16

Similar Documents

Publication Publication Date Title
IL143761A0 (en) Biodegradable polymer encapsulated serotonin receptor antagonist and method for preparing the same
EP1171961A4 (en) SYSTEM AND METHOD FOR MEASURING TROUGH
ZA994812B (en) Method for filling voids with aggregate material.
HUP0104914A3 (en) Galenicformulations fast disintegrating the mouth and method for preparing same
SG80041A1 (en) Muscarinic receptor antagonists
PL356990A1 (en) Isoxazolecarboxamide derivatives as alpha1-adrenergic receptor antagonists
IL138245A0 (en) Vitronectin receptor antagonists
IL142045A0 (en) Naphthalenecarboxamides as tachykinin receptor antagonists
GB2354219B (en) Method and system for exploiting natural resources under the seabed
IL148043A0 (en) Novel integrin receptor antagonists
HUP9903480A3 (en) Indoline derivatives useful as 5-ht-2c receptor antagonists
PL348702A1 (en) Vitronectin receptor antagonist
PL352777A1 (en) Integrin receptor antagonists
EP1137938A4 (en) METHODS FOR DETECTION OF HDPXU17 RECEPTOR AGONISTS AND ANTAGONISTS
SG83788A1 (en) Method for preparing polymer
AU3611099A (en) Oxindole derivatives used as neurokinin receptor antagonists
HUP9903439A3 (en) Indoline derivatives useful as 5-ht-2c receptor antagonists
IL141163A0 (en) Vitronectin receptor antagonists
HUP0100857A3 (en) Method for preparing sulfanyl-type endothelin receptor antagonists
GB9811283D0 (en) Vironectin receptor antagonists
GB9807940D0 (en) Alpha-1a adrenergic receptor antagonists
GB9923910D0 (en) Prolactin receptor
HK1038180A (en) Vitronectin receptor antagonists
GB9603373D0 (en) Integrin receptor antagonists
GB9812686D0 (en) Vitronectin receptor antagonists

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed